On 2025-05-13, Lyell Immunopharma, Inc. (LYEL) announced earnings per share of $-3.60 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-3.80.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-3.80 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-3.80 | $-3.60 |
| 2025-03-11 | 2024-12-31 | $-3.60 | $-14.40 |
| 2024-11-07 | 2024-09-30 | $-4.00 | $-3.40 |
| 2024-08-07 | 2024-06-30 | $-4.00 | $-3.60 |
| 2024-05-06 | 2024-03-31 | $-4.00 | $-4.80 |
| 2024-02-28 | 2023-12-31 | $-4.20 | $-4.00 |
| 2023-11-07 | 2023-09-30 | $-5.40 | $-4.00 |
| 2023-08-08 | 2023-06-30 | $-6.00 | $-5.20 |
| 2023-05-04 | 2023-03-31 | $-5.60 | $-5.40 |
| 2023-02-28 | 2022-12-31 | $-6.20 | $-0.60 |
| 2022-11-08 | 2022-09-30 | $-6.80 | $-5.60 |
| 2022-08-04 | 2022-06-30 | $-6.20 | $-3.00 |
| 2022-05-10 | 2022-03-31 | $-5.40 | $-5.60 |
| 2022-03-29 | 2021-12-31 | -- | $-3.60 |
| 2021-11-12 | 2021-09-30 | $-5.40 | $-4.00 |
| 2021-08-12 | 2021-06-30 | $-30.80 | $-25.00 |